Seeking Clues to Pacira (PCRX) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics

Core Viewpoint - Wall Street analysts anticipate Pacira (PCRX) will report quarterly earnings of $0.86 per share, reflecting a year-over-year decline of 3.4%, while revenues are expected to be$ 184.01 million, an increase of 1.5% from the previous year [1] Earnings Projections - Changes in earnings projections are crucial for predicting investor reactions to the stock, with empirical studies showing a strong correlation between earnings estimate trends and short-term stock price movements [2] Analyst Forecasts - Analysts project that 'Revenue- Net product sales- EXPAREL' will reach $145.33 million, indicating a year-over-year change of +1% [4] - The consensus for 'Revenue- Net product sales- ZILRETTA' is$ 30.72 million, reflecting a +7% change from the year-ago quarter [4] - For 'Revenue- Net product sales- iovera', analysts estimate $6.36 million, which represents a +5.4% change from the previous year [4] Total Revenue Estimates - The combined estimate for 'Revenue- Total net product sales' is projected to be$ 183.38 million, indicating a year-over-year change of +2% [5] Stock Performance - Pacira shares have seen a -1.6% change over the past month, compared to a -1.8% move in the Zacks S&P 500 composite, with a Zacks Rank 1 (Strong Buy) suggesting expected outperformance in the near future [5]